To evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and efficacy of the dual GLP‐1R/GIPR agonist BGM0504 in Chinese adults with overweight or obesity without diabetes.
L. Ji, Guo-Ping Yang, Yang-Qing Huang et al.· Diabetes, obesity and metabo...· 0 citations
Background Diabetes patients often exhibit suboptimal efficacy and adverse reactions, accompanied by pharmacokinetic (PK) changes, indicating drug-metabolizing enzymes and transporters (DMET) activities may change. This study aimed to determine whether type 2 diabetes affects DMET activities and quantify impact magnitu...
Ya-Fen Li, Jin Yang, En-Da Zhou et al.· Frontiers in Pharmacology· 0 citations
BACKGROUND
NH600001 is a novel intravenous anesthetic developed as a safer alternative to etomidate. Its pharmacokinetic/pharmacodynamic (PK/PD) profile and optimal dosing in elderly patients remain insufficiently characterized. This study aimed to develop a population PK/PD model of NH600001 and evaluate age‑related d...
Ya-Jie Cao, Yun Kuang, Qi Gao et al.· Expert Opinion on Drug Metab...· 0 citations
Simcyp provides a refined depiction of skin physiological structure and is widely applied in clinical evaluation and special population prediction and Skin-CAD focuses more on the mechanistic description of TDS formulations, while GastroPlus focuses more on the mechanistic description of TDS formulations.
Ya-Fen Li, Yu-Xiao Li, Ya-Xin Liu et al.· Drug Delivery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.